Forbes, A., Hobart, M., Ouyang, J., Shi, L., Pfister, S., & Hakala, M. (2018). A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia. Int J Neuropsychopharmacol.
Chicago ZitierstilForbes, Andy, Mary Hobart, John Ouyang, Lily Shi, Stephanie Pfister, und Mika Hakala. "A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole As Maintenance Treatment in Adults With Schizophrenia." Int J Neuropsychopharmacol 2018.
MLA ZitierstilForbes, Andy, et al. "A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole As Maintenance Treatment in Adults With Schizophrenia." Int J Neuropsychopharmacol 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.